World's first kidney transplants using a new anti-rejection drug performed in Bologna

In Bologna, the first kidney transplants using a new anti-rejection drug, Cizutamig, have been successfully performed on two patients with low compatibility chances. This innovative treatment, developed by Candid Therapeutics, aims to prevent organ rejection and could significantly impact patients on transplant waiting lists. The two recipients, who had waited 13 years for compatible organs, are showing excellent organ function months post-surgery. The success of this drug may also extend to other transplant types, such as heart transplants, offering hope for a broader range of patients.